Page last updated: 2024-11-02

pd 98059 and Acute Liver Injury, Drug-Induced

pd 98059 has been researched along with Acute Liver Injury, Drug-Induced in 1 studies

2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one: inhibits MAP kinase kinase (MEK) activity, p42 MAPK and p44 MAPK; structure in first source
2-(2-amino-3-methoxyphenyl)chromen-4-one : A member of the class of monomethoxyflavones that is 3'-methoxyflavone bearing an additional amino substituent at position 2'.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Marra, F1
Arrighi, MC1
Fazi, M1
Caligiuri, A1
Pinzani, M1
Romanelli, RG1
Efsen, E1
Laffi, G1
Gentilini, P1

Other Studies

1 other study available for pd 98059 and Acute Liver Injury, Drug-Induced

ArticleYear
Extracellular signal-regulated kinase activation differentially regulates platelet-derived growth factor's actions in hepatic stellate cells, and is induced by in vivo liver injury in the rat.
    Hepatology (Baltimore, Md.), 1999, Volume: 30, Issue:4

    Topics: Animals; Calcium-Calmodulin-Dependent Protein Kinases; Carbon Tetrachloride; Cell Division; Cell Mov

1999